Article Text

PDF

GW23-e0507
POLY(ADP-RIBOSE) POLYMERASE INHIBITOR REDUCES HEART ISCHAEMIA/REPERFUSION INJURY VIA INFLAMMATION AND AKT SIGNALLING
  1. Song Zhao-feng1,
  2. Chen Dong-yu2,
  3. Du Bo1,
  4. Wang Li-zhen1,
  5. Wang Fan1,
  6. Qi Xin-yan1,
  7. Zhou Qing-hua1,
  8. Song Zhao-feng1
  1. 1Department of Cardiology, Taian Central Hospital, 271000 Taian, Shandong Province, China
  2. 2Department of Rheumatology, Taian Central Hospital, 271000 Taian, Shandong Province, China

    Abstract

    Objectives Poly (ADP-ribose) polymerase (PARP) has been proposed to play an important role in the pathogenesis of heart ischaemia/reperfusion (I/R) injury. 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (DPQ), a novel, potent PARP inhibitor, has been proved to have cardiac protective effects. However, the underlying mechanisms are still not thoroughly understood. In this study, we investigate the effect of DPQ on heart I/R injury and its potential mechanisms.

    Methods Studies were performed with I/R rats' hearts. DPQ was used to inhibit the activate of PARP. The myocardial infarction size, cardiac function and cells apoptosis were detected. The activation of PARP, transcription factor nuclear factor-kappaB (NF-κB), intercellular adhesion molecule-1 (ICAM-1), cyclooxygenase-2 (COX-2) and Matrix metalloproteinase-9 (MMP-9) were evaluated during the I/R protocol.

    Results Our data showed that DPQ could reduce the rat heart I/R injury in vivo. Heart I/R caused a significant increase in PARP activity. Administration of DPQ could decrease the activation of PARP. At the same time, administration of DPQ could decrease myocardial infarction size from 60.97±4.22% to 39.03±3.94% (p<0.05) and cells apoptosis from 35±5.3% to 20±4.1% (p<0.05) and simultaneously improved the cardiac function. In addition, we found that DPQ reduced the expression of NF-κB, ICAM-1, COX-2 and MMP-9 in rat heart. At the same time, DPQ facilitated Akt activation and decreased the activity of its downstream target, glycogen synthase kinase-3β (GSK-3β) and the forehead transcription factor FOXO3a.

    Conclusions Our results suggested that the inhibition of PARP was able to reduce heart I/R injury. The protective effects of DPQ were associated with both inflammation and Akt signalling.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.